Court To Hear Arguments In High-Stakes Suit Over Zyprexa
A federal court in Indiana will hear arguments Monday in the high-stakes battle for Eli Lilly's top-selling drug, the $4.3-billion-a-year schizophrenia medicine Zyprexa....To view the full article, register now.
Already a subscriber? Click here to view full article